Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$11.8 - $17.1 $8,260 - $11,970
-700 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$17.0 - $17.78 $11,900 - $12,446
700 New
700 $12,000

Others Institutions Holding FUSN

About Fusion Pharmaceuticals Inc.


  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.